𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Central nervous system imaging in reevaluation of patients with neurofibromatosis type 1

✍ Scribed by P. Balestri; L. Calistri; R. Vivarelli; G. Bartalini; L. Mancini; A. Berardi; A. Fois


Publisher
Springer
Year
1993
Tongue
English
Weight
426 KB
Volume
9
Category
Article
ISSN
0256-7040

No coin nor oath required. For personal study only.

✦ Synopsis


We report the results of the reevaluation of 24 patients with neurofibromatosis type 1 (NF1) using central nervous system (CNS) imaging techniques. The first examination by computed tomography (CT) or magnetic resonance imaging (MRI) indicated the presence of optic glioma in three cases, "unidentified bright objects" (UBOs) in six, and a suspected right frontal tumor in one. In two patients optic glioma and UBOs were both present and in one of them a bulbar tumor was also suspected. Later imaging examinations revealed the appearance of optic glioma in three more cases and UBOs in nine. In two of these patients both optic glioma and UBOs were present. This study indicates that the likelihood of detecting imaging abnormalities in patients with NF1 increases when systematic follow-up is performed. Optic gliomas are characteristic of pediatric patients; they rarely give rise to clinical manifestations (1/6 cases) and in general progress very slowly. For these reasons, therapeutic strategy must be carefully considered and individually decided. UBOs are very frequent findings in pediatric patients with NF 1 and therefore they must be considered diagnostically relevant. They are not related to clinical manifestations and spontaneous regression has been observed. The nature of these imaging abnormalities is still unknown, but because they do not behave like tumors, useless and dangerous therapeutic procedures should not be employed.


πŸ“œ SIMILAR VOLUMES


High incidence of thromboembolism in pat
✍ Neta Goldschmidt; Eduard Linetsky; Edna Shalom; David Varon; Tali Siegal πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 60 KB

## Abstract ## BACKGROUND Venous thromboembolism (VTE) is a frequent complication in patients with cancer throughout the course of the disease. Patients with brain tumors are at particularly high risk for VTE, and several risk factors were found in patients with malignant glioma. To the authors' k